BICO Group AB’s Nomination Committee for the 2026 Annual General Meeting
October 10, 2025 7:00 amBICO Group’s major owners have appointed a Nomination Committee and the Annual General Meeting of BICO Group AB will be held on Thursday May 7, 2026.
In accordance with the decision by the Annual General Meeting 2025 when the most recent principles regarding the composition of the nomination committee were adopted, the Nomination Committee of BICO Group AB shall consist of four members appointed by the largest shareholders. The Chairman of the Board shall not be a member of the Nomination Committee but shall normally be co-opted to the meeting of the Nomination Committee.
The four largest shareholders who wish to participate in the Nomination Committee are entitled to appoint one member each. In preparation for the 2026 Annual General Meeting the members of the Nomination Committee have been appointed based on the ownership structure as of September 30, 2025.
The Nomination Committee for the 2026 Annual General Meeting consists of the following members:
- Anders Strid, nominated by Erik Gatenholm (Chairman of the Nomination Committee)
- Carl-Johan Krusell, nominated by Héctor Martínez
- Jannis Kitsakis, nominated by the Fourth Swedish National Pension Fund (AP4)
- Malin Björkmo, nominated by Handelsbanken Funds
- Maria Rankka, Board Chair of BICO Group AB (co-opted)
Shareholders having appointed members to the Nomination Committee represent approximately 44 percent of the voting rights for all shares of BICO Group AB. The Nomination Committee has also appointed Anders Strid as Chairman of the Nomination Committee.
The Nomination Committee will prepare proposals for the Annual General Meeting 2026 regarding election of chairman/woman and other directors of the board, election of auditor, matters regarding fees, election of chairman/woman of the Annual General Meeting and resolution concerning the Nomination Committee.
Shareholders who wish to submit proposals to the Nomination Committee ahead of the Annual General Meeting 2026 are welcome to contact the Nomination Committee by email: ir@bico.com. Please write “To the Nomination Committee” in the subject line or per mail:
BICO Group AB
att. Nomination Committee
Grafiska vägen 2B
412 63 Gothenburg
Sweden
Proposals shall be submitted in writing in due time before the Annual General Meeting, no later than January 31, 2026, to ensure that the proposals can be considered by the Nomination Committee.
For further information, please contact:
Maria Rankka, Board Chair, BICO Group AB
Phone: +46 (0) 702-10 11 44
E-mail: ir@bico.com
The information was submitted for publication, through the agency of the contact person set out above, on October 10, 2025 at 7am CEST.
About BICO
BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 10,900 publications. Operating through two business areas – Lab Automation and Life Science Solutions – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com